0001104659-22-118684.txt : 20221114
0001104659-22-118684.hdr.sgml : 20221114
20221114164859
ACCESSION NUMBER: 0001104659-22-118684
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220930
FILED AS OF DATE: 20221114
DATE AS OF CHANGE: 20221114
EFFECTIVENESS DATE: 20221114
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RiverVest Venture Management LLC
CENTRAL INDEX KEY: 0001812549
IRS NUMBER: 431900629
STATE OF INCORPORATION: MO
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-21321
FILM NUMBER: 221386932
BUSINESS ADDRESS:
STREET 1: 101 S. HANLEY ROAD
STREET 2: SUITE 1850
CITY: ST. LOUIS
STATE: MO
ZIP: 63105
BUSINESS PHONE: 314-726-6700
MAIL ADDRESS:
STREET 1: 101 S. HANLEY ROAD
STREET 2: SUITE 1850
CITY: ST. LOUIS
STATE: MO
ZIP: 63105
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001812549
XXXXXXXX
09-30-2022
09-30-2022
false
RiverVest Venture Management LLC
101 S. Hanley Road
Suite 1850
St. Louis
MO
63105
13F HOLDINGS REPORT
028-21321
N
Sivan Weitzman
Chief Financial Officer
314-726-6700
/s/ Sivan Weitzman
St. Louis
MO
11-14-2022
0
0
0
INFORMATION TABLE
2
infotable.xml
Allakos, Inc.
Common
01671P100
29914
4887932
SH
OTR
3349223
1538709
0
Spruce Bioscience, Inc.
Common
85209E109
2943
2148281
SH
SOLE
2148281
0
0
Vapotherm, Inc.
Common
922107107
648
412558
SH
OTR
0
412558
0
Mirum Pharmaceuticals, Inc.
Common
604749101
40363
1921118
SH
SOLE
1921118
0
0
Reneo Pharmaceuticals, Inc.
Common
75974E103
8071
2409220
SH
SOLE
2409220
0
0
Xilio Therapeutics, Inc.
Common
98422T100
4195
1441444
SH
SOLE
1441444
0
0